News

Eosinophilic esophagitis (EoE) is a long-term immune system disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. Scientists think this may happen when ...
Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...
Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...
Nat Clin Pract Gastroenterol Hepatol. 2006;3(5):285-289. In the adult population, eosinophilic esophagitis tends to be chronic, but stable, with no significant effect on morbidity or mortality.
Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build up in the esophagus, the tube that moves food and liquids from the throat to the stomach. This buildup of ...
NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...
As a result, the man underwent a biopsy of his esophagus, which showed he was suffering from eosinophilic esophagitis, a chronic immune condition that causes an accumulation of eosinophil cells ...
In a US study, patients with severe eosinophilic esophagitis (EoE) by Index of Severity for EoE had poor responses to topical corticosteroid therapy.
Apogee targets a multi-billion dollar market with differentiated biologics, aiming for significant market share in atopic dermatitis, asthma, and eosinophilic esophagitis. With recent financial ...
The others are atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease (COPD). Dupixent has been ...
1) Bell, CF., Lau, M., Shen, Q. Clinical and Economic Characteristics of Patients Diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome) in the United ...
Fexuclue, a novel potassium-competitive acid blocker (PCAB), is approved as a new treatment for adults with erosive esophagitis of all grades. Sun Pharma has obtained rights from Daewoong ...